Inspek
Grant-FundedCORDISAn innovative on-chip multi-sensing platform for single-use biopharmaceutical applications
Deep Tech · Semiconductors · Biotech
The growth of biomanufacturing, characterised by an ever-increasing number of bioproduced molecules including life-saving drugs, is hampered by high bioprocessing failure rates that incur over $2 billion in annual losses for companies like Johnson & Johnson. It is also associated with significant environmental impacts, particularly in sterilisation processes. Single-use technologies have emerged
as a solution, yet they require advanced sensing capabilities for full effectiveness. InSpek addresses this need with its multi-sensoron- a-chip technology, utilising waveguide-enhanced Raman spectroscopy (WERS) and Photonic Integrated Circuits (PIC). Our PICs
integrate essential bioprocessing sensors — Raman spectroscopy, temperature, pH, dissolved oxygen, and others — into a single, compact platform. InSpek's non-invasive technology outperforms traditional sensors in cost and efficiency, enhancing real-time bioprocess monitoring and reducing the development time for new biotherapies.
EU Grants€2.5M
Open to funding
Team
JM
Jérôme Michon
Founder
All-time revenue—
MRRPrivate••••••
FounderJérôme Michon
Founded—
🇫🇷France
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Business detailsB2B
Deep TechSemiconductorsBiotech
Tags:Deep TechSemiconductorsBiotech
Looking for:InvestmentPartnerships
Company Info
Inspek Info
Funding
EU Grants€2.5M
Open to funding
